Latest news
Loading news…
Amgen
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Thousand Oaks, California, United States Founded 1980 10001+ employees For Profit
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
26
Investments
19
11 exits
Monthly Visits
Available in Pro Contacts
5,271
Ticker
AMGN
NASDAQ
Patents
3,002
384 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- AMGN
- Exchange
- NASDAQ
- IPO date
- Jun 17, 1983
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 114
- Mobile apps
- 43
- Downloads (30d)
- 19
- Active products
- 40
- Patents granted
- 3,002
- Trademarks
- 384
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $797.62M
Investor Activity
- Investments
- 19
- Lead investments
- 7
- Portfolio orgs
- 16
- Diversity investments
- 7
- Exits
- 11
- Exits via IPO
- 10
Company Info
- Founded
- 1980
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 3
- News articles
- 3,693
- Events
- 10
- HQ
- Thousand Oaks, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
- Exit date
- Jun 17, 1983
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.9
- Trend (90d)
- 0
- Last leadership hire
- Aug 1, 2026
- Last layoff mention
- Mar 10, 2026
Investments by Amgen
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Amgen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Amgen
Chief Executive Officer
Executive Vice President of RandD, and Chief Scientific Officer
Board of Director
Field Director East - Neuroscience
Board of Director
Director Process Development
Board of Director
Global Strategic Sourcing Category Senior Manager
Director of Product Management
Scientific Director
Country Director
Executive Vice President Human Resources
Global Development Lead
Regulatory Strategic Innovation Leader
Executive Director, R&D & CMC Operations
Director of Commercial Information Management
Chief Technology Officer
Senior Vice President and CIO
Senior Manager, Biosimilars Tender & Contracting
Vice President, Global Development Operations
Executive Director
Senior Software Engineer
SVP, General Counsel and Secretary
Vice President External Operations
5,271
professional contacts at Amgen
Contact execs at Amgen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Amgen
Loading news…
FAQs about Amgen
People who checked this page also checked these
Sectors Amgen invests & acquires in
Browse the full Acquirezy directory.